ADVERTISEMENT
Search

Test to Treat for Paxlovid

Test to Treat for Paxlovid

Pharmacists are now permitted to order and prescribe the oral antiviral, Paxlovid, under certain conditions, for eligible patients who test positive for COVID-19. FDA recently recognized pharmacists’ expertise by revising Paxlovid’s EUA to include pharmacists among other health care professionals permitted to prescribe this therapeutic medication.
More information about implementing testing and treatment services is provided below.
Act now: Tell Congress payment for pharmacist prescribing of Paxlovid is critical

Pharmacists now have the authority to prescribe Paxlovid for the treatment of mild to moderate COVID-19 disease under certain conditions. While updating the emergency use authorization (EUA) was a huge step forward, there is no current federal policy providing coverage for the associated clinical services required for pharmacist prescribing.

Use our prewritten, editable advocacy alert to ask your U.S. representatives to contact HHS and CMS to identify a payment pathway to reimburse pharmacists for their prescription of Paxlovid.

Take action 

APhA Training and Important Resources


APhA Advocacy


APhA continues to advocate that CMS and other payers take immediate action to provide adequate and appropriate payment for pharmacist test to treat services.